Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14973126 | 0.89 | MAPT (0.57) | SMN1; SMN2ALDH1A1LMNAPOLBNPC1 | |
| SCHEMBL14973188 | 0.88 | TSHR (0.52) | SMN1; SMN2ALDH1A1LMNAPOLBNPC1 | |
| SCHEMBL14972952 | 0.85 | MAPT (0.52) | SMN1; SMN2ALDH1A1POLBNPC1RAB9A | |
| SCHEMBL14973299 | 0.85 | JMJD6 (0.45) | SMN1; SMN2ALDH1A1LMNAGPR55NPC1 | |
| SCHEMBL14972975 | 0.85 | NR4A2 (0.47) | SMN1; SMN2ALDH1A1LMNANPC1RAB9A | |
| SCHEMBL14972961 | 0.81 | MRGPRX4 (0.43) | SMN1; SMN2ALDH1A1NPC1RAB9AMAPT | |
| SCHEMBL14973085 | 0.81 | ALDH1A1 (0.43) | SMN1; SMN2ALDH1A1NPC1RAB9AMAPT | |
| SCHEMBL14973272 | 0.80 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1LMNARAB9AMAPT | |
| SCHEMBL14973111 | 0.79 | PAX8 (0.47) | SMN1; SMN2ALDH1A1POLBNPC1RAB9A | |
| SCHEMBL14973180 | 0.78 | BRAF (0.47) | SMN1; SMN2NPC1RAB9AMAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2604602-A1 | HETEROARYL-PYRAZOLE DERIVATIVE | Taisho Pharmaceutical Co., Ltd. (JP) | 2013-06-19 | — | — | EP | disclosed |
| US-20130137865-A1 | HETEROARYL-PYRAZOLE DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2013-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130137865-A1 | HETEROARYL-PYRAZOLE DERIVATIVE | GRIN2C, GRIN2B, GRIN3A | SMN1; SMN2 3612/4885ALDH1A1 2263/4885LMNA 4849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.